Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004047 |
ID: | TCMBANKHE004047 |
植物拉丁名: |
|
功能与主治: | To induce subsidence of swelling and remove toxic substances, to cause purgation./Swelling toxin of welling abscess and flat abscess, throat impediment, scrofula, dry stool. |
药用植物名: | 蓖麻子 |
药用部位: | ripe seed |
药味: | Mild; Pungent; Sweet |
经络: | Lung; Large Intestine |
治疗类型: | 拔毒化腐生肌药 |
TCM_ID_id: | 5699 |
SymMap_id: | 44 |
TCMSP_id: | 54 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000885 | Sebiferic acid | AC1NT0B0; 3-[4,9,10,14-tetramethyl-3,17-bis(prop-1-en-2-yl)-2,3,5,6,7,8,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-4-yl]propanoic acid; sebiferic acid; sebifericacid; 3-[1,2,6,11-tetramethyl-5,14-bis(prop-1-en-2-yl)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadecan-6-yl]propanoic acid | C30H48O2 | 440.7 | CC(=C)C1CCC2(C1CCC3(C2CCC4C3(CCC(C4(C)CCC(=O)O)C(=C)C)C)C)C |
| TCMBANKIN001178 | Nouracid CS 80 | R7257_SIGMA; (9Z)-12-hydroxyoctadec-9-enoic acid; (9Z)-(12S)-Hydroxyoctadecenoic acid; 12R-hydroxy-9Z-octadecenoic acid; 141-22-0; 12-Hydroxyoctadeca-9-enoic acid; (R)-12-Hydroxy-cis-9-octadecenoic acid; InChI=1/C18H34O3/c1-2-3-4-11-14-17(19)15-12-9-7-5-6-8-10-13-16-18(20)21/h9,12,17,19H,2-8,10-11,13-16H2,1H3,(H,20,21)/b12-9-/t17-/m1/s; 12-D-Hydroxy-9-cis-octadecenoic acid; CHEBI:28592; 12-hydroxyoleic acid; 12-Hydroxy-9-octadecenoic acid; (9Z,12R)-12-hydroxyoctadec-9-enoic acid; 83903_FLUKA; Ricinoleic acid; C08365; NCGC00161336-01; LMFA01050233; 12-Hydroxy-cis-9-octadecenoic acid; (Z,12R)-12-hydroxyoctadec-9-enoic acid | C18H34O3 | 298.46 | CCCCCCC(CC=CCCCCCCCC(=O)O)O |
| TCMBANKIN001478 | Riddelline | riddelline | C18H23NO6 | 349.38 | CC=C1CC(=C)C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(CO)O |
| TCMBANKIN004621 | 15ξ-hydroxypinusolidicacid | C20H28O5 | CC12CCCC(C1CCC(=C)C2CCC3=CC(OC3=O)O)(C)C(=O)O | ||
| TCMBANKIN004874 | Suberogorgin | suberogorgin; (3R,8aS)-1-Oxo-3beta,5aalpha,8alpha-trimethyl-1,2,3,3abeta,4,5,5a,8-octahydrocyclopenta[c]pentalene-7-carboxylic acid; CHEMBL453238; Subergorgic acid | C15H20O3 | 248.32 | CC1CC(=O)C23C1CCC2(C=C(C3C)C(=O)O)C |
| TCMBANKIN005818 | Thujopsadiene | thujopsadiene; AC1O575L; 2,4a,8,8-tetramethyl-1,1a,4,5-tetrahydrocyclopropa[j]naphthalene; HIRCZOSUMSSTDU-UHFFFAOYSA-N | C15H22 | 202.33 g/mol | CC1=CCC2(CC=CC(C23C1C3)(C)C)C |
| TCMBANKIN008151 | pinusolidicacid | C20H28O4 | 332.4 g/mol | CC12CCCC(C1CCC(=C)C2CCC3=CCOC3=O)(C)C(=O)O | |
| TCMBANKIN009809 | 7,7''-di-o-methylcupressu-flavone | 5-hydroxy-8-[5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-8-yl]-2-(4-hydroxyphenyl)-7-methoxychromen-4-one; 8,8''-Bisgenkwanin; AC1NSUUS | C32H22O10 | 566.5 g/mol | COC1=C(C2=C(C(=C1)O)C(=O)C=C(O2)C3=CC=C(C=C3)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)OC |
| TCMBANKIN010314 | 1,4-dimethyl-cis-cyclohexane | C8H16 | CC1CCC(CC1)C | ||
| TCMBANKIN013791 | cosbene | C20H32 | CC1=CCCC(=CC2C(C2(C)C)CCC(=CCC1)C)C | ||
| TCMBANKIN013903 | ricin | ||||
| TCMBANKIN014260 | Costaclavine | 6,8-Dimethylergoline; costaclavine; Costaclavin; (2S,4R,7R)-4,6-DIMETHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),9,12,14-TETRAENE; AC1L4NNM; 436-41-9; Ergoline, 6,8-dimethyl-, (8beta,10beta)-; Epicostaclavin; Pyroclavin | C16H20N2 | 240.34 g/mol | CC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C |
| TCMBANKIN016060 | fenchyl alcohol | (1R)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-ol; ZINC968128; UNII-410Q2GK1HF component IAIHUHQCLTYTSF-OYNCUSHFSA-N; Bicyclo[2.2.1]heptan-2-ol, 1,3,3-trimethyl-, (1R,2R,4S)-; OW0KEP592N; (1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol; UNII-32Y92U27DU component IAIHUHQCLTYTSF-OYNCUSHFSA-N; AC1Q2CCL; 2-Norbornanol, 1,3,3-trimethyl-, endo-; alpha-Fenchol; J-014563; Bicyclo(2.2.1)heptan-2-ol, 1,3,3-trimethyl-, (1R,2R,4S)-; DSSTox_RID_80144; Ambap1632-73-1; alpha-Fenchyl alcohol, (+)-; 14575-74-7; (+)-Fenchol, analytical standard; DSSTox_CID_24307; (1R-Endo)-fenchol; NCGC00255994-01; (+)-alpha-Fenchol; AC1L1UKL; DTXSID6044307; BG00600801; Fenchyl alcohol, analytical standard; (1R,3R,4S)-2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol; (1S,3R,4R)-2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol; UNII-OW0KEP592N; alpha-(+)-Fenchol; Dl-alpha-Fenchol; AC1OE1YY; bmse000495; Fenchyl alcohol, >=96%, FG; FEMA no. 2480, alpha-; DSSTox_GSID_44307; MFCD00003760; alpha-Fenchol, (+)-; Tox21_301348; 2217/2/9; (1R)-endo-(+)-Fenchyl alcohol; FENCHYL ALCOHOL; Fenchylalkohol; CAS-2217-02-9; Fenchyl alcohol, >=96%; AKOS028109357; ()-Fenchol; CHEMBL3188732; (+/-)-alpha-Fenchol; Bicyclo(2.2.1)heptan-2-ol, 1,3,3-trimethyl-, endo-; (1R)-endo-(+)-Fenchyl alcohol, 96%; alpha-Fenchyl alcohol | C10H18O | 154.25 g/mol | CC1(C2CCC(C2)(C1O)C)C |
| TCMBANKIN019026 | 9,10-dihydroxystearicacid | D8539_SIGMA; (9R,10R)-Dihydroxyoctadecanoic acid; UNII-SQL1V605V5; Threo-9,10-dihydroxyoctadecanoic acid; ZINC30726317; 9,10-dihydroxystearic acid; C08314; threo-9,10-Dihydroxystearic acid; UNII-6C8DC6UQ5A component VACHUYIREGFMSP-IAGOWNOFSA-N; UNII-SQL1V605V5 component VACHUYIREGFMSP-IAGOWNOFSA-N; (9R,10R)-9,10-Dihydroxyoctadecanoic acid; LMFA01050527; Octadecanoic acid, 9,10-dihydroxy-, threo-; FT-0667157; Octadecanoic acid, 9,10-dihydroxy-, (9R,10R)-rel-; Octadecanoic acid, 9,10-dihydroxy-, (R*,R*)-; 9,10-Dihydroxystearic acid, threo- | C18H36O4 | 316.5 g/mol | CCCCCCCCC(C(CCCCCCCC(=O)O)O)O |
| TCMBANKIN023474 | ODD | 94594_FLUKA; (10E,12Z)-10,12-Octadecadienoic acid; trans-10, cis-12-octadecadienoic acid; CHEBI:44526; Linoleic acid (10-trans, 12-cis); (10E,12Z)-octadeca-10,12-dienoic acid; 10E,Z12-CLA; 10E,12Z-octadecadienoic acid; Conjugated (10E,12Z)-Linoleic acid solution; LMFA01030125 | C18H32O2 | 280.45 | CCCCCC=CC=CCCCCCCCCC(=O)O |
| TCMBANKIN025750 | C-Curarine | C-Curarin I; 69356-55-4; LS-55730; Toxiferine I, 18,18'-dideoxy-2,2'-epoxy-; C-Curarine I; 18,18'-Dideoxy-2,2'-epoxytoxiferine I; c-curarine; EINECS 230-517-9; C-Curarine-I | C40H44N4O+2 | 596.8 g/mol | CC=C1C[N+]2(CCC34C2CC1C5=CN6C7=CC=CC=C7C89C61C(=CN(C53O1)C1=CC=CC=C41)C1CC8[N+](CC9)(CC1=CC)C)C |
| TCMBANKIN028010 | lambertianicacid | lambertianic acid; lambertian acid | C20H28O3 | 316.4 g/mol | CC12CCCC(C1CCC(=C)C2CCC3=COC=C3)(C)C(=O)O |
| TCMBANKIN031727 | dimelicacid | dimelic acid | C7H12O4 | C(CCC(=O)O)CCC(=O)O | |
| TCMBANKIN033425 | ricinoleic acid | 12-hydroxyoleate; ricinoleicacid; 12-hydroxy-(9Z)-octadecenoate; (9Z)-12-hydroxyoctadec-9-enoate; CHEBI:85150 | C18H34O3 | 298.46 | CCCCCCC(CC=CCCCCCCCC(=O)[O-])O |
| TCMBANKIN033426 | isocupressicacid | C20H32O3 | 320.5 g/mol | CC(=CCO)CCC1C(=C)CCC2C1(CCCC2(C)C(=O)O)C | |
| TCMBANKIN033920 | phosphatidylcholine | phosphatidyl choline | 314.29 | CCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC | |
| TCMBANKIN035877 | juniperic acid | 16-hydroxy hexadecanoic acid; CHEBI:55329; A828204; 16-Hydoxy hexadecanoic acid; omega hydroxy hexadecanoate (n-C16:0); hydroxy hexadecanoate; omega-hydroxy-hexadecanoate; AC1OEJUS; w-hydroxy hexadecanoic acid; 16-hydroxy-hexadecanoate; 16-oxidanylhexadecanoate; w-hydroxy hexadecanoate; omega-hydroxy hexadecanoate; omega hydroxy hexadecanoic acid; 16-Hydoxy hexadecanoate; omega-hydroxy hexadecanoic acid; hydroxy hexadecanoic acid; 16-HYDROXYPALMITATE; omega-hydroxy-palmitate; omega hydroxy hexadecanoate; 16-hydroxyhexadecanoate | C16H32O3 | 272.42 g/mol | C(CCCCCCCC(=O)O)CCCCCCCO |
| TCMBANKIN036816 | baicalin | 21967-41-9; STOCK1N-21299; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 5,6,7-Trihydroxyflavone-7-O-.beta.-D-glucopyranosideuronic acid; C10025; Baicalin; AIDS001402; 100647-26-5; 7-D-Glucuronic acid-5,6-dihydroxyflavone; 5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl beta-D-glucopyranosiduronic acid; 31564-28-0; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-keto-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; Baicalein-7-D-glucuronide; TJN-151; CHEBI:2981; (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl; LMPK12111081; baicalin ; 5,6-dihydroxy-4-oxo-2-phenyl-4H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid; Baicalein 7-O-glucuronide; 27462-75-5; Baicalein 7-glucuronide; AIDS-001402; (2S,3S,4S,5R,6S)-6-[(5,6-dihydroxy-4-oxo-2-phenyl-7-chromenyl)oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; 572667_ALDRICH | C21H18O11 | 446.36 | C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O |
| TCMBANKIN036900 | corilagin | Corilagin; C10219; .beta.-D-Glucopyranose, cyclic 3,6-[(1R)-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate] 1-(3,4,5-trihydroxybenzoate); 23094-69-1; AIDS-025842; beta-D-Glucopyranose, cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), (R)-; AIDS025842; corilagin | C27H24O17 | 620.469 | c1(O[H])c(c(c(C([H])=O)c([H])c(O[H])c2O[H])c2O[H])c([H])c(C(OC([H])([H])[C@@]3([H])O[C@@]([H])(OC(c4c([H])c(O[H])c(O[H])c(O[H])c4[H])=O)[C@]([H])(O[H])C([H])([H])[C@]3([H])O[H])=O)c(O[H])c1O[H] |
| TCMBANKIN037593 | 7beta,12-Dimethoxy-8,11,13-abietatrien-11-ol | 7beta,12-dimethoxy-8,11,13-abietatrien-11-ol; (4bS,10S)-3,10-dimethoxy-4b,8,8-trimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-4-ol; AC1NSUSM; 7β,12-dimethoxy-8,11,13-abietatrien-11-ol | C22H34O3 | 346.56 | CC(C)C1=C(C(=C2C(=C1)C(CC3C2(CCCC3(C)C)C)OC)O)OC |
| TCMBANKIN037981 | Myricetin-3-O-α-L-rhamnoside | myricetin-3-o-alpha-l-rhamnoside | 463.4 g/mol | ||
| TCMBANKIN038922 | fenchone | CHEMBL2269327; (1R)-1,3,3-Trimethylbicyclo[2.2.1]heptan-2-one; SCHEMBL7997210; (1R)-1,3,3-Trimethylbicyclo[2.2.1]heptane-2-one; AC1MDS7B; (4R)-2,2,4-trimethylbicyclo[2.2.1]heptan-3-one | C10H16O | 152.23 | CC1(C2CCC(C2)(C1=O)C)C |
| TCMBANKIN039557 | amentoflavone | BDBM50129952; CTK8F7701; CC-24050; Q-100192; 8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; 1617-53-4; CHEBI:2631; AC1NQYPA; 5,5',7,7'-Tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-[3,8'-bi-4H-1-benzopyran]-4,4'-dione; 8-[5-(5,7-dihydroxy-4-oxo-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; MFCD00017470; N2268; DTXSID20167225; HMS3343J17; amentoflavone ; C10018; 40584_FLUKA; MFCD20275041; 2-(3-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl)-4-hydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; 8-[5-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-1-benzopyran-4-one; A810291; CS-4945; AIDS000485; NSC295677; UNII-9I1VC79L77; KS-00000037; 8-[5-(5,7-dihydroxy-4-keto-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; ZINC3984030; NCGC00247542-01; SR-01000721725; SCHEMBL312563; HMS2228B12; 8-[5-(5,7-dihydroxy-4-oxo-2-chromenyl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; 3',8''-Biapigenin; Didemethyl-ginkgetin; amentoflavone; 9I1VC79L77; cid_5281600; SC-13592; 8-[5-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenyl]-2-(4-hydroxyphenyl)-5,7-bis(oxidanyl)chromen-4-one; YUSWMAULDXZHPY-UHFFFAOYSA-N; AN-49542; BIDD:PXR0028; 4H-1-Benzopyran-4-one, 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; D06HRX; 3',8-Bi[4',5,7-trihydroxyflavone]; MolPort-001-741-078; 4H-1-Benzopyran-4-one, 8-[5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl); MEGxp0_000924; 8-[5-(5,7-Dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxy-phenyl]-5,7-dihydroxy-2-(4-hydroxy-phenyl)-chromen-4-one; SMR000156235; 8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; W1536; Amentoflavone, >=99.0% (HPLC); HY-N0662; MLS000574827; SR-01000721725-2; Amenthoflavone; C-23136; NSC-295677; LMPK12040009; 8-(5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; I07-0160; 79596-89-7; CHEMBL63354; 4H-1-Benzopyran-4-one,8-[5-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-; SR-01000721725-3; FT-0622262; AIDS-000485; AKOS015896819; 4',4''',5,5'',7,7''-Hexahydroxy-3''',8-biflavone, 8CI; NSC 295677; BG01783910; Tridemethylsciadopitysin; Amentoflavone, analytical standard; 617A534; Ambotz1617-53-4; 4',5,7-Trihydroxyflavone(3'->8)-4',5,7-trihydroxyflavone | C30H18O10 | 538.458 | c12c(OC(c3c([H])c([H])c(O[H])c(c(c(O[H])c([H])c4O[H])c(OC(c5c([H])c([H])c(O[H])c([H])c5[H])=C([H])C6=O)c46)c3[H])=C([H])C1=O)c([H])c(O[H])c([H])c2O[H] |
| TCMBANKIN040269 | myricitrin | 3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; Myricetin 3-O-rhamnoside; 17912-87-7; Myricetrin; 5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-2-(3,4,5-trihydroxyphenyl)-4-chromenone; MLS000574998; Myricetin 3-O-alpha-L-rhamnopyranoside; 3,3',4',5,5',7-Hexahydroxyflavone 3-O-Rhamnoside; Myricitrin (8CI); AIDS-011946; M2361; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; NCGC00163596-01; Myricitrin; Myricetin 3-O-alpha-L-rhamnoside; NSC 19803; 5,7-Dihydroxy-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2-(3,4,5-trihydroxy-phenyl)-1-benzopyran-4-one; MEGxp0_000257; C10108; myricetin-3-O-rhamnose; ACon1_000103; SCHEMBL226023; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromone; SMR000232363; AIDS011946; EINECS 241-856-7; LMPK12112436; 5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | C21H20O12 | 464.376 | c1(O[H])c([H])c(C2=C(O[C@]3([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]3([H])O[H])C(=O)c4c(c([H])c(O[H])c([H])c4O[H])O2)c([H])c(O[H])c1O[H] |
| TCMBANKIN042468 | kaempferol-7-o-glucoside | C21H20O11 | 448.4 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O | |
| TCMBANKIN043315 | 8(9),15-Isopimaradien-3β-ol | ||||
| TCMBANKIN043417 | Quercitrin-2''-gallate | ||||
| TCMBANKIN044058 | 15-isopimaren-3β,8β-diol | C20H34O2 | CC1(C2CCC3(CC(CCC3C2(CCC1O)C)(C)C=C)O)C | ||
| TCMBANKIN047698 | 8(14),15-Isopimaradien-3β,19-diol | ||||
| TCMBANKIN057933 | coriose;D-Altro-3-heptulose | 1,2,4,5,6,7-hexahydroxyheptan-3-one; AC1NSTTI | C7H14O7 | 210.18 g/mol | C(C(C(C(C(=O)C(CO)O)O)O)O)O |
| TCMBANKIN057968 | subericacid | suberic acid;LMFA01170001; NSC 25952; AIDS002602; AI3-52672; Hexamethylenedicarboxylic acid; Carboxylic acids, di-, C4-11; Suberic acid; NSC53777; C08278; 1,8-Octanedioic acid; NSC25952; 60930_FLUKA; S5200_ALDRICH; 68937-72-4; ST5307924; NCGC00164012-01; EINECS 208-010-9; 1,6-Hexanedicarboxylic acid; EINECS 273-084-1; nchembio815-comp1c; AIDS-002602; 505-48-6; Octanedioic acid;Cork acid | C8H14O4 | 174.19 g/mol | C(CCCC(=O)O)CCC(=O)O |
| TCMBANKIN057971 | sebacicacid | AC1MI2Z2; EINECS 256-186-0; ACM45037670; sebacic acid; 45037-67-0; DTXSID50196366; Sebacaldehyde; decanedial; CTK1D8105; SCHEMBL453083; Usaf hc-1; 4-02-00-02078 (Beilstein Handbook Reference); 422088_ALDRICH; 26776-29-4; 4-OXODECANEDIOIC ACID; AI3-09127; S1752_ALDRICH; 4-OXOSEBACIC ACID; n-Decanedioic acid; Decanedicarboxylic acid; Mixture of undecanedioic acid; CHEBI:41865; Decanedioic acid; 4,7-DIOXOSEBACIC ACID; 14047-57-5; NSC19492; 111-20-6; EINECS 203-845-5; Sebacic acid; 32734-00-2; BRN 1210591; WLN: QV8VQ; NCGC00164361-01; Decanedioic acid, homopolymer; AIDS002604; Dodecanedioic acid and sebacic acid; Sebacic acids; 283258_ALDRICH; 1,8-Octanedicarboxylic acid; NSC 19492; C08277; CCRIS 2290; Sebacinsaeure; NCI60_001628; Polysebacic polyanhydride; Sebacinsaure [German]; Acide sebacique [French]; 84809_FLUKA; NCIOpen2_008624; 84810_FLUKA; AIDS-002604; 1,10-Decanedioic acid; LMFA01170006; CORFREE M1; decanedioic acid | C10H18O4 | 202.25 g/mol | C(CCCCC(=O)O)CCCC(=O)O |
| TCMBANKIN058076 | myricetin | 3,3′,4′,5,5′,7-Hexahydroxyflavone; Lopac0_000740; EU-0100740; Myricetin; SPBio_002509; NCGC00015697-01; CAS-529-44-2; C10107; TNP00286; CHEBI:58395; S00115; NSC407290; ST057235; KBio2_001981; MYC; EINECS 208-463-2; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4-chromenone; NCI60_003870; 2-(3,4,5-TRIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-4H-1-BENZOPYRAN-4-ONE; Myricitin; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-; Cannabiscetin; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromone; ZINC03860925; myricetin ; BSPBio_000570; NSC-407290; CHEBI:18152; Prestwick_342; Spectrum5_000692; M6760_SIGMA; 5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-olate; NCGC00094083-04; 3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one; ACon1_000267; Prestwick2_000465; NCGC00015697-02; 3,3',4',5,5',7-Hexahydroxyflavone; CCRIS 5838; FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY-; 70050_FLUKA; KBio2_007117; AIDS-001411; 529-44-2; 5-18-05-00670 (Beilstein Handbook Reference); KBioGR_001884; 3,5,7-TRIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE; Prestwick3_000465; KBio2_004549; Prestwick1_000465; Myricetol; NSC 407290; KBioSS_001981; AIDS001411; NCGC00015697-03; BRN 0332331; Lopac-M-6760; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)- (9CI); myricetin(1-); NCGC00094083-02; SpecPlus_000531; BPBio1_000628; 3,5,7,3',4',5'-Hexahydroxyflavone; 3,3'4'5,5'7-hexOH-Flavone; DivK1c_006627; MEGxp0_000357; Spectrum_001501; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; Prestwick0_000465; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; KBio1_001571; Spectrum4_001272; HY-15097; NCGC00015697-06; SPBio_002509; NCGC00015697-01; ST057235; KBio2_001981; 3,7,3',4',5'-Hexahydroxyflavone; Q-100601; LP00740; IKMDFBPHZNJCSN-UHFFFAOYSA-N; AN-939; 2-(3,4,5-TRIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-4H-1-BENZOPYRAN-4-ONE; M-1214; NCGC00094083-01; HMS1569M12; NCGC00015697-13; CM0160; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; NSC-407290; BS0289; 4CN-1085; MCULE-6299186219; SR-01000076005-1; HSDB 7682; KS-00000GOF; 529-44-2; KBioGR_001884; LS-69005; BRN 0332331; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)- (9CI); AKOS015903103; BPBio1_000628; 3,5,7,3',4',5'-Hexahydroxyflavone; C07E0ED2-ABF6-4BD3-A2B2-A98CAEF20FD1; NCGC00015697-05; DivK1c_006627; DB02375; NCGC00015697-10; Flavone,3',4',5,5',7-hexahydroxy-; Spectrum4_001272; MolPort-001-740-532; MLS006010718; TNP00286; CCG-204825; Myricetin (Cannabiscetin); Myricetin, >=96.0%, crystalline; KS-5268; SR-01000076005; NCI60_003870; AB0149714; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-; BIDD:PXR0079; SMR001233193; HMS3262C22; I14-19097; BSPBio_000570; Spectrum5_000692; 3,3 ,4 ,5,5 ,7-Hexahydroxyflavone; NCGC00094083-04; 3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one; FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY-; NCGC00094083-03; 529M442; NCGC00015697-09; 3,3',4',5,5',7-hexahydroxy-(8CI)- flavone; KBioSS_001981; cid_5281672; NCGC00015697-03; BBL023468; NCGC00094083-02; NCGC00179517-02; SpecPlus_000531; BC201817; HMS2231L04; BG01607805; A829320; NCGC00179517-01; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; KBio1_001571; FT-0672573; STL284709; REGID_for_CID_5281672; S00115; myricetin; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one #; EINECS 208-463-2; MFCD00006827; AK111247; CHEBI:18152; GL5441; NCGC00261425-01; BIDD:ER0142; s2326; ACon1_000267; Prestwick2_000465; CCRIS 5838; KBio2_007117; 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-; MLS002153825; Prestwick1_000465; Prestwick3_000465; Bio-0838; KBio2_004549; NCGC00015697-07; Myricetol; Lopac-M-6760; BDBM15236; HMS2096M12; Myricetin, >=96.0% (HPLC); MEGxp0_000357; Spectrum_001501; 76XC01FTOJ; TR-018746; Prestwick0_000465; ST24041172; M 6760; AJ-46397; Lopac0_000740; EU-0100740; CAS-529-44-2; C10107; NSC407290; Myricetin from Myrica cerifera leaf and bark; 4gqr; 2o63; AC-4533; MYC; NCGC00015697-08; N1850; Myricitin; Cannabiscetin; D0T3PW; HMS3656I05; Tox21_500740; NCGC00015697-04; NCGC00015697-12; DTXSID8022400; Prestwick_342; 3,5,7-tris(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one; CS-6221; M2131; ZINC3874317; BRD-K43149758-001-04-5; CHEBI: 18152; 3,3',4',5,5',7-hexOH-Flavone; NCGC00015697-02; 3,3',4',5,5',7-Hexahydroxyflavone; Myricetin, analytical standard; UNII-76XC01FTOJ; NSC 407290; LMPK12110001; AX8140581; AC1NQYV4; SCHEMBL19302; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyran-4-one; SR-01000076005-6; CHEMBL164; NCGC00015697-11; 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; Myricetin, primary pharmaceutical reference standard; 3,3',4',5,5',7-hexahydroxyflavone | C15H10O8 | 318.23 g/mol | C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN058217 | kaempferol-7-O-β-D-glucopyranoside | 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; kaempferol 7-O-β-D-glucopyranoside; kaempferol-7-o-glucoside; 3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | C21H20O11 | 448.4 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O |
| TCMBANKIN058224 | Cupressuflavone | 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-8-chromenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; cupressuflavone ; 3952-18-9; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; ST5331567; Cupressiflavone; C10034; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8,8''-Biapigenin | C30H18O10 | 538.46 | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O)O |
| TCMBANKIN058227 | Inokiflavone | 4H-1-Benzopyran-4-one, 6-(4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihyd- roxy-2-(4-hydroxyphenyl)-; AIDS003062; 6-(4-(5,7-Dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; AIDS-003062; Hinokiflavone; 6-[4-(5,7-dihydroxy-4-oxo-chromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 4H-1-Benzopyran-4-one, 6-(4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 6-[4-(5,7-dihydroxy-4-oxo-2-chromenyl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; 6-[4-(5,7-dihydroxy-4-keto-chromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; EINECS 242-877-4; C10057; 19202-36-9; 6-[4-(5,7-dihydroxy-4-oxochromen-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one;hinokiflavone;hinokiflavone ; SCHEMBL617273; LMPK12040004 | C30H18O10 | 538.46 g/mol | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)OC4=CC=C(C=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O |
| TCMBANKIN058233 | aromadendrol | A827424; dihydrokaempferol; (2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxochroman-7-olate; (2R,3R)-3,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-5-olate; (2R,3R)-2-(4-hydroxyphenyl)-3,7-bis(oxidanyl)-4-oxidanylidene-2,3-dihydrochromen-5-olate; (+)-dihydrokaempferol 7-oxoanion; CHEBI:57294 | C15H12O6 | 288.25 g/mol | C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058322 | baicalein | 5,6,7-trihydroxyflavanone; KBio3_002435; NCGC00025282-03; 5,6,7-trihydroxy-2-phenyl-chromen-4-one; AIDS-000731; 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one; baicalein ; Sho-saiko-to; 5,6,7-trihydroxy-2-phenylchromen-4-one; ST057152; Spectrum_000427; SPECTRUM1504002; 5,6,7-trihydroxy-2-phenyl-chromone; KBio1_001798; KBio2_006043; NSC 661431; 11712_FLUKA; SDCCGMLS-0066744.P001; KBioSS_000907; CHEBI:2979; SMP1_000037; 5,6,7-trihydroxy-2-phenyl-4-chromenone; LMPK12140610; SPBio_000572; NCGC00025282-02; Dihydrobaicalein; Baicalein; 5,6,7-trihydroxy-2-phenyl-chroman-4-one; Spectrum4_000537; KBioGR_001173; 491-67-8; NCGC00017236-01; S00113; 465119_ALDRICH; Spectrum5_001418; Oprea1_765614; Tocris-1761; DivK1c_006854; NSC729192; AIDS000731; BSPBio_003215; SCHEMBL12068882; 5,6,7-Trihydroxyflavone; Spectrum3_001608; KBio2_003475; SpecPlus_000758; 5,6,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one; NSC661431; NCGC00025282-01; 5,6,7-trihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; C10023; Spectrum2_000466; TNP00121; KBio2_000907; ZINC00017881; Biacalein; 5,6,7-trihy-droxyflavone | C15H10O5 | 270.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O |
| TCMBANKIN058467 | Hinokinin | Cubebinolide; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)-2-tetrahydrofuranone; CTK1F0599; 2(3H)-Furanone, dihydro-3,4-dipiperonyl-, trans-(-)-; hinokinin; 2(3H)-Furanone, 3,4-bis(1,3-benzodioxol-5-ylmethyl)dihydro-, (3R-trans)-; (+)-Hinokinin; DDWGQGZPYDSYEL-CABCVRRESA-N; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)oxolan-2-one; (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)tetrahydrofuran-2-one; CHEMBL180970; 2(3H)-Furanone, 3,4-bis(1,3-benzodioxol-5-ylmethyl)dihydro-, (3S,4S)-; 3,4-Bis(1,3-benzodioxol-5-ylmethyl)dihydro-2(3H)-furanone #; 580-73-4; 26543-89-5; DTXSID40451491; (3S,4S)-3,4-BIS(2H-1,3-BENZODIOXOL-5-YLMETHYL)OXOLAN-2-ONE; C10627; ZINC900115; SCHEMBL14064757 | C20H18O6 | 354.35g/mol | C1C(C(C(=O)O1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 |
| TCMBANKIN059020 | adenanthin k | 2α,7β,13α-triacetoxy-5α,9α-dihydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one, (3 e,7 e)-2α,10β,13α-triacetoxy-5α,20-dihydrox-y-3,8-seco-taxa-3,7,11-trien-9-one | C26H36O9 | 492.6 g/mol | CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C |
| TCMBANKIN059521 | B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene | C10H16 | 136.23 g/mol | CC1(C2CCC(=C)C1C2)C | |
| TCMBANKIN059645 | isopimaric acid | C20H30O2 | 302.5 g/mol | CC1(CCC2C(=CCC3C2(CCCC3(C)C(=O)O)C)C1)C=C | |
| TCMBANKIN059672 | longikaurin g | C20H28O6 | 364.4 g/mol | CC1(CCCC23C1C(C(C45C2C(CC(C4O)C(=C)C5=O)O)(OC3)O)O)C | |
| TCMBANKIN060024 | thunbergol | C20H34O | 290.48 | CC1=CCCC(C=CC(CCC(=CCC1)C)C(C)C)(C)O | |
| TCMBANKIN060119 | 16-hydroxy-8(17),13-ent-labdadien-15,16-olid-19-oicacid | C20H28O5 | CC12CCCC(C1CCC(=C)C2CCC3=CC(=O)OC3O)(C)C(=O)O | ||
| TCMBANKIN060121 | pinusolide | C21H30O4 | 346.5 g/mol | CC12CCCC(C1CCC(=C)C2CCC3=CCOC3=O)(C)C(=O)OC | |
| TCMBANKIN060122 | lambertianicacid | C20H28O3 | 316.4 g/mol | CC12CCCC(C1CCC(=C)C2CCC3=COC=C3)(C)C(=O)O | |
| TCMBANKIN060160 | quercitrin | C21H20O11 | 448.4 g/mol | CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O | |
| TCMBANKIN060332 | thujene | C10H16 | 136.23 g/mol | CC1C=CC2(C1C2)C(C)C | |
| TCMBANKIN060879 | Linolic acid | C18H32O2 | 280.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061110 | 10-nonacosanol | C29H60O | 424.8 g/mol | CCCCCCCCCCCCCCCCCCCC(CCCCCCCCC)O | |
| TCMBANKIN061293 | ricinine | C8H8N2O2 | 164.16 g/mol | CN1C=CC(=C(C1=O)C#N)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab